Priser
Platform
Blog
Om os
Download
002007
Hualan Biological Engineering
Shenzhen Stock Exchange (Hong Kong)
0

Om

Hualan Biological Engineering Inc. is a key player in the biopharmaceutical industry, primarily focused on the research, development, and manufacturing of human vaccines and blood products. As a prominent biopharmaceutical company, Hualan Biological Engineering is dedicated to advancing healthcare through innovative vaccine solutions and high-quality blood derivatives, catering to various health concerns. The company's products are essential in combatting infectious diseases and supporting immune health, significantly influencing public health sectors and biotechnological advancements. By ensuring stringent quality control and employing cutting-edge technologies, Hualan Biological Engineering contributes robustly to the healthcare and pharmaceutical markets. The firm maintains a strong commitment to safety and efficacy in all its offerings, making it a vital asset in the healthcare industry.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I HUALAN BIOLOGICAL ENGINEERING MED ENDAVU: Køb Hualan Biological Engineering ($002007) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Hualan Biological Engineering, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Information

Ticker002007
Land
Kina
Antal medarbejdere4.117
Hjemmesidehualanbio.com
SektorSundhed
IndustriBioteknologi

Udbytter

0,4CNH
'20
0,3CNH
'21
0,2CNH
'22
0,3CNH
'23
0,3CNH
'24
0,7CNH
'25
Ex-udbytte-dato27. okt. 2025
Udbytteafkast3,45%

Analytikerskøn

Baseret på 7 analytikere

Stærkt købKøbHoldSælgStærkt sælg
14%71%14%0%0%